These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30891152)

  • 1. Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron.
    Xourgia E; Papazafiropoulou A; Melidonis A
    World J Diabetes; 2019 Mar; 10(3):169-180. PubMed ID: 30891152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus.
    Ren T; Liu J; Ge Y; Zhuo R; Peng L; Liu F; Jin X; Yang L
    Neurochem Int; 2019 Oct; 129():104501. PubMed ID: 31299417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of rutin in diabetes-induced deficits in acquisition learning, retention memory and pain perception in rats.
    Hasanein P; Emamjomeh A; Chenarani N; Bohlooli M
    Nutr Neurosci; 2020 Jul; 23(7):563-574. PubMed ID: 30321127
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic Theory in Anti-Alzheimer's Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents.
    Jankowska A; Wesołowska A; Pawłowski M; Chłoń-Rzepa G
    Curr Med Chem; 2020; 27(39):6658-6681. PubMed ID: 31604406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus.
    Pelle MC; Zaffina I; Giofrè F; Pujia R; Arturi F
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.
    Wang Y; Wu L; Li J; Fang D; Zhong C; Chen JX; Yan SS
    J Alzheimers Dis; 2015; 43(2):451-63. PubMed ID: 25096625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Alzheimer's disease a type 3 diabetes? A review.
    Janoutová J; Machaczka O; Zatloukalová A; Janout V
    Cent Eur J Public Health; 2022 Sep; 30(3):139-143. PubMed ID: 36239360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of Glycogen Metabolism with Concomitant Spatial Memory Dysfunction in Type 2 Diabetes: Potential Beneficial Effects of Chronic Exercise.
    Soya M; Jesmin S; Shima T; Matsui T; Soya H
    Adv Neurobiol; 2019; 23():363-383. PubMed ID: 31667816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal Medicines for Diabetes Management and its Secondary Complications.
    Kumar S; Mittal A; Babu D; Mittal A
    Curr Diabetes Rev; 2021; 17(4):437-456. PubMed ID: 33143632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contributions of impaired adult hippocampal neurogenesis to occurrence and development of diabetic encephalopathy].
    Zhang Q; Xu SJ
    Sheng Li Xue Bao; 2022 Oct; 74(5):837-842. PubMed ID: 36319106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities.
    Bednarz K; Siuda J
    Neurol Neurochir Pol; 2021; 55(5):418-428. PubMed ID: 34355790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
    Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
    Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA
    Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive dysfunction and dementia associated with elderly diabetes].
    Kouta Y; Sakurai T; Yokono K
    Nihon Rinsho; 2006 Jan; 64(1):119-23. PubMed ID: 16408458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
    Muñoz-Jiménez M; Zaarkti A; García-Arnés JA; García-Casares N
    Dement Geriatr Cogn Disord; 2020; 49(5):423-434. PubMed ID: 33080602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Insulin Resistance to Treat Cognitive Dysfunction.
    Tyagi A; Pugazhenthi S
    Mol Neurobiol; 2021 Jun; 58(6):2672-2691. PubMed ID: 33483903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease.
    Das S; Ramachandran AK; Halder D; Akbar S; Ahmed B; Joseph A
    CNS Neurol Disord Drug Targets; 2023; 22(7):973-993. PubMed ID: 35770411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic Drugs in the Treatment of Alzheimer's Disease.
    Michailidis M; Tata DA; Moraitou D; Kavvadas D; Karachrysafi S; Papamitsou T; Vareltzis P; Papaliagkas V
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.
    Jayaraj RL; Azimullah S; Beiram R
    Saudi J Biol Sci; 2020 Feb; 27(2):736-750. PubMed ID: 32210695
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.